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bilization compared to the control group by ISH and qPCR. The expression
was not changed after immobilization compared to the control group by
IHC and WB. Expressions of CTGF and TGF-β1were increased after the ﬁrst
2-week immobilization and then decreased by ISH, and increased gradually
by IHC compared to the control group.
Conclusions: The expression of mRNAand protein levels of collagen types
I and III were not increased after immobilization, which indicated that
accumulation of the two types of collagen was not the etiology of joint
contracture. However, ﬁborogenetic factors of CTGF and TGF-β1 were
increased. Another process, such as capsule and synovial adhesions or
collagen cross-linking, may be possible causes of joint contracture.
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PROSTAGLANDIN D2 ENHANCES INTERLEUKIN -1BETA- INDUCED
CYCLOOXYGENASE-2 EXPRESSION IN OSTEOARTHRITIC SYNOVIOCYTES
N. Zayed, N. Chabane, F. El Mansouri, J. Martel-pelletier, J.-P. Pelletier,
h. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: To investigate the effects of prostaglandin D2 (PGD2) on
interleukin-1beta (IL-1beta)-induced cyclooxygenase (COX)-2 expression
in human synoviocytes and the signalling pathways involved in these
effects.
Methods: Synoviocytes were stimulated with IL-1 in the presence or
absence of PGD2, and expression of COX-2 protein was evaluated by
western-blotting. Messenger RNA (mRNA) expression was analyzed by
real-time reverse transcription-polymerase chain reaction. The role of
the PGD2 receptors D prostanoid receptor 1 (DP1) and chemoattractant
receptor-like molecule expressed on Th2 cells (CRTH2) was evaluated using
speciﬁc agonists.
Results: PGD2 increased in a dose-dependent manner IL-1-induced COX-2
protein and mRNA expression. DP1 and CRTH2 were expressed and func-
tional in synoviocytes. The effect of PGD2 was mimicked by DK-PGD2 and
Indomethacin, selective agonists of CRTH2, but not by BW245C, a selective
agonist of DP1. Furthermore, treatment with an anti-CRTH2 antibody re-
versed the effect of PGD2, indicating that the stimulatory effect of PGD2
is mediated by CRTH2. Activation of CRTH2 is consistent with the activa-
tion of a receptor coupled to a phosphoinositide-speciﬁc phospholipase,
suggesting that the effect of PGD2 is mediated by the CRTH2/PIP2/PKC.
Conclusions: PGD2 enhances IL-1-induced production of COX-2 by syn-
oviocytes through the CRTH2/PIP2/PKC signalling pathway.
Matrix Biochemistry
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ELEVATED LEVELS OF COLLAGEN TYPE III IN ARTICULAR CARTILAGE OF
OSTEOARTHRITIC JOINTS
S. Hosseininia1 , L. Dahlberg1, L. Kim2, S. Funk2, M. Weis2, D. Eyre2
1Lund Univ., Malmö, Sweden; 2Univ. of Washington, Seattle, WA
Purpose: To determine differences between well-deﬁned OA and control
human articular cartilage samples in type III collagen content.
Methods: Full-depth, intact surface cartilage from 5 OA (aged 60-80, 4
women) and 5 reference (aged 78-87, 5 women) femoral heads were
obtained at total hip replacement surgery for osteoarthritis (OA) or femoral
neck fracture.
1 mg/ml α-chymotrypsin plus inhibitors was added to each diced sample
(incubated at 32°C overnight) to remove susceptible collagen components.
An aliquot of the supernatant was freeze-dried and used for SDS-PAGE
and another aliquot was hydrolyzed in 6M HCl at 110°C to be assayed for
hydroxyproline (μg/mg wet wt.) colorimetrically.
SDS-PAGE and Western blots were run using mAb 1C10, which recognizes
a sequence-speciﬁc epitope in α1(II) CB9,7 and mAb 4G9, which recognizes
a conformational epitope in the collagen III N-propeptide domain.
A competition ELISA was run on the same extracts using the 4G9 mAb
to quantify the collagen III N-propeptide levels extracted from OA and
reference cartilage samples.
Results: There was more extractable collagen in the OA than in the
reference cartilage, 5% and 2%, respectively (p=0.02).
From OA and normals, most of the extracted collagen ran as intact α1(II)
chains and large fragments on mAb 1C10 SDS-PAGE/Western (Fig. 2A).
Figure 1. Model of Type III collagen polymerized on Type II collagen ﬁbrils.
The major band stained in the SDS-PAGE/4G9 Western blot is the
cleaved N-propeptide trimer of collagen III released from the matrix by
α-chymotrypsin (Fig. 2B).
The ELISA results show a ﬁve-fold higher mean content of type III collagen
in OA hip cartilage versus fracture hip controls (Fig. 2B).
Figure 2. A. SDS-PAGE/Western blot of collagen type II in articular cartilage chy-
motrypsin extracts. B. SDS-PAGE/Western blot and an ELISA analysis of collagen type III
N-propeptide domain released from articular cartilage by chymotrypsin.
Conclusions: Our study conﬁrms previous results showing an increased
pool of extractable collagen in OA. In the present study we additionally
show that this extractable pool includes degradation products of type III
collagen.
The results show that grossly normal looking cartilage from joints under-
going degenerative disease (OA) develops a signiﬁcantly altered collagen
phenotype as shown by the synthesized and deposited collagen III in the
matrix of the OA compared with non-OA joints of similar age.
Previously it has been suggested that collagen III is made by the condro-
cytes in response to matrix damage similar to the wound-healing role of
collagen III in type I collagen-based tissues.
The covalent addition of collagen III to the ﬁbrillar matrix that occurs
in both normal and OA human articular cartilage suggests an active
remodeling process.
It remains to be established if increased amount of collagen III at sites of
superﬁcially intact, full thickness OA cartilage reﬂects pathological activity,
an active repair mechanism or both.
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INFRAPATELLAR FAT PAD CAN INDUCE FIBROTIC PROCESSES IN
CULTURED SYNOVIOCYTES
Y.M. Bastiaansen-Jenniskens1 , R. Stoop2, C. Feijt1, J. Verhaar1,
R. Hanemaaijer3, G. van Osch1
1Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands; 2TNO Quality of Life,
Leiden, Netherlands; 3TNO Quality of Live, Leiden, Netherlands
Purpose: Stiffening of the joint is one of the features of knee osteoarthritis,
which can be caused by ﬁbrosis of the synovial tissue within the joint.
In this study, we investigated whether the adipose tissue in the joint
(infrapatellar fat pad) excretes cytokines and growth factors that could be
involved in ﬁbrosis.
